Studies have shown that active fund managers routinely underperform the S&P500 index*​

PMV Pharmaceuticals, Inc. (NASDAQ: PMVP)

PMVP Stock Predictions and Ratings

WSX Rating:
NOT AVAILABLE
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
BUY
Analyst Forecast (1yr):
115.50%

PMVP Stock Analysis

PMVP PE Ratio:

PMVP PEG Ratio: Not Available

PMVP Forward EPS Growth (12 month): 0.00%

PMVP PS Ratio:

PMVP PSG Ratio: Not Available

PMVP Forward Revenue Growth (12 month): 0.00%

PMVP Articles

No data was found